Wire · opportunities
Where AI Is Leading and Lagging in Pulmonary and Critical Care
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 9 July 2026 · Fusion42 review
AI is advancing in pulmonary and critical care diagnostics—particularly for COPD detection, ILD, and pulmonary hypertension—but faces maturity gaps, narrow clinical focus, and generalizability challenges. Radiology applications dominate FDA approvals (76% of ~1400 devices), while wearable-AI integration shows promise in reducing exacerbations and ED visits.
This Wire brief sits within Fusion42's coverage of Digital Health.
◆ ◆ The Wire takeaway
Pulmonary AI diagnostics show clinical validation (COPD detection AUC 0.93, PH diagnosis AUC 0.83) and economic impact (98% ED visit reduction with wearable integration), but narrow model training and single-center datasets create a go-to-market opportunity for generalist clinical AI platforms addressing cross-population deployment barriers.
◆ Coverage
1 source · 9 Jul 2026
◆ Related on Wire
◆ Topics